Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Statistics in Medicine
|
April 11, 2009
Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting
Ismaïl Ahmed, Françoise Haramburu, Annie Fourrier-Réglat, et al.
Epidemiology (Cambridge, Mass.)
|
February 28, 2008
Impact of prescriber nonresponse on patient representativeness
Annie Fourrier-Réglat, Cécile Droz-Perroteau, Jacques Bénichou, et al.
Plos Medicine
|
July 19, 2017
Prescription medicine use by pedestrians and the risk of injurious road traffic crashes: A case-crossover study
Mélanie Née, Marta Avalos, Audrey Luxcey, et al.
Targeted Oncology
|
October 13, 2017
Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients: a Study Using the International Pharmacovigilance Database
Amandine Gouverneur, Pauline Claraz, Marine Rousset, et al.
Journal of the American Geriatrics Society
|
January 3, 2007
Evolution of prevalence of depressive symptoms and antidepressant use between 1988 and 1999 in a large sample of older French people: Results from the personnes agées quid study
Delphine Montagnier, Pascale Barberger-Gateau, Hélène Jacqmin-Gadda, et al.
Targeted Oncology
|
December 6, 2013
Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort
Annie Fourrier-Réglat, Denis Smith, Magali Rouyer, et al.
European Journal of Clinical Pharmacology
|
March 6, 2014
Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation
Francesco Salvo, Emanuel Raschi, Ugo Moretti, et al.
BMC Medicine
|
April 21, 2017
Antidepressant use and cognitive decline in community-dwelling elderly people - The Three-City Cohort
Isabelle Carrière, Joanna Norton, Amandine Farré, et al.
Pharmacoepidemiology and Drug Safety
|
February 26, 2009
Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study
Pernelle Noize, Fabienne Bazin, Carole Dufouil, et al.
Leukemia & Lymphoma
|
September 24, 2015
Patterns and effectiveness of bortezomib use according to age in the VESUVE cohort
Angela Grelaud, Annie Fourrier-Réglat, Olivier Fitoussi, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Statistics in Medicine
|
April 11, 2009
Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting
Ismaïl Ahmed, Françoise Haramburu, Annie Fourrier-Réglat, et al.
Epidemiology (Cambridge, Mass.)
|
February 28, 2008
Impact of prescriber nonresponse on patient representativeness
Annie Fourrier-Réglat, Cécile Droz-Perroteau, Jacques Bénichou, et al.
Plos Medicine
|
July 19, 2017
Prescription medicine use by pedestrians and the risk of injurious road traffic crashes: A case-crossover study
Mélanie Née, Marta Avalos, Audrey Luxcey, et al.
Targeted Oncology
|
October 13, 2017
Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients: a Study Using the International Pharmacovigilance Database
Amandine Gouverneur, Pauline Claraz, Marine Rousset, et al.
Journal of the American Geriatrics Society
|
January 3, 2007
Evolution of prevalence of depressive symptoms and antidepressant use between 1988 and 1999 in a large sample of older French people: Results from the personnes agées quid study
Delphine Montagnier, Pascale Barberger-Gateau, Hélène Jacqmin-Gadda, et al.
Targeted Oncology
|
December 6, 2013
Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort
Annie Fourrier-Réglat, Denis Smith, Magali Rouyer, et al.
European Journal of Clinical Pharmacology
|
March 6, 2014
Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation
Francesco Salvo, Emanuel Raschi, Ugo Moretti, et al.
BMC Medicine
|
April 21, 2017
Antidepressant use and cognitive decline in community-dwelling elderly people - The Three-City Cohort
Isabelle Carrière, Joanna Norton, Amandine Farré, et al.
Pharmacoepidemiology and Drug Safety
|
February 26, 2009
Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study
Pernelle Noize, Fabienne Bazin, Carole Dufouil, et al.
Leukemia & Lymphoma
|
September 24, 2015
Patterns and effectiveness of bortezomib use according to age in the VESUVE cohort
Angela Grelaud, Annie Fourrier-Réglat, Olivier Fitoussi, et al.
Page
of 8